Macleods Pharmaceutical Limited

Macleods Pharmaceuticals Ltd. is a global pharmaceutical company. Foundation of Macleods was laid by visionary and enterprising individual, Dr. Rajendra Agarwal in 1986, when he ventured on his own to create a history in the Indian Pharmaceutical Industry by choosing Anti-TB as a focused area of operation and went on to make Macleods as one of the major global supplier of entire first line and second line Anti-TB drugs.

Macleods has its presence in more than 80 countries. With established presence in South East Asia, Asia Pacific,Africa, North America, EU & EEA, MENA, Latin America and CIS countries and evolving presence in many regulated and emerging markets. Macleods is now making its presence felt in the global pharmaceutical market.

Macleods operates its International business through various business models like Private Markets, Tenders, Licensing, Contract manufacturing and Joint Ventures.

Macleods has successfully leveraged its production and Research & development competency for supplying affordable quality pharmaceuticals across the globe.

Macleods has business presence in the following countries.

CIS markets
Russia, Ukraine, Kazakhstan, Azerbaijan, Kyrgyzstan, Uzbekistan, Belarus, Georgia, Turkmenistan.

South East Asia
Vietnam, Myanmar, Thailand, Philippines, Srilanka, Malaysia, Cambodia.

Africa
Angola, Botswana, Lesotho, Ethiopia, Kenya, Ghana, Malawi, Zambia, Tanzania, Ivory Coast, Nigeria, Mauritius, Sudan, Uganda, Zimbabwe, Mozambique, Rwanda, Lestho, Madagascar, Senegal, Benin, Burkinafaso, Niga, Togo, Cameroon, Namibia, Swaziland & South Africa.

Latin America
Peru, Colombia, Chile, Caribbean Islands, Venezuela.

Middle East
UAE, Saudi Arabia, Yemen, Iraq and Iran.